US2016310539A1PendingUtilityA1
Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
Est. expiryMay 13, 2023(expired)· nominal 20-yr term from priority
A61K 38/1875A61K 39/3955A61K 38/1841A61K 39/395C12Y 304/21005A61K 35/28A61K 47/34A61K 38/18A61K 38/17G01N 33/6869A61K 38/4833A61K 38/363A61K 45/06G01N 2333/54A61K 9/0085A61K 9/0012A61K 38/20A61K 9/0019A61K 35/32A61P 19/00A61B 17/7061A61K 38/1793
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method of treating a patient having a degenerating disc, comprising the step of:
a) injecting into the disc a formulation comprising:
i) cultured, allograft intervertebral disc cells; and
ii) fibrinogen; and
b) forming within the disc a fibrin matrix derived from the fibrinogen that provides a scaffold for new tissue growth.
22 . The method of claim 21 , wherein the formulation further comprises iii) thrombin.Join the waitlist — get patent alerts
Track US2016310539A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.